We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

SHINE study

Advertisement

cGxPJobs Banner

Zervimesine Phase 3 Plan Advances Alzheimer’s Drug Strategy

Purchase, N.Y. — December 1, 2025 — Cognition Therapeutics has unveiled its Phase 3 registrational plan for Zervimesine (CT1812)...

By cGxPwire Editor
December 2, 2025

Read More

Advertisement

cGxPJobs

Recent Posts

01

.Clinical

Nanobiotix Updates Phase 3 NANORAY-312 Protocol
May 5, 2026
02

Bio-Pharma

Opus Genetics Enters FDA RDEP Program for OPGx-LCA5
May 5, 2026
03

Bio-Pharma

Cellenkos Secures FDA IND Clearance for CK0802 in GVHD Trial
May 5, 2026
04

Pharma

Johnson & Johnson Highlights CAPLYTA Superiority in MDD Study
May 5, 2026
05

MedTech

Telix Pharmaceuticals Publishes TLX250-Px Kidney Study
May 5, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website